NCT03660436View on ClinicalTrials.gov

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

October 10, 2018

Study Completion Date

October 18, 2018

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Specified dose on specified days

DRUG

MMF

Specified dose on specified days

Trial Locations (1)

84107

PRA Health Sciences, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03660436 - An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants | Biotech Hunter | Biotech Hunter